“Efficacy and Safety of Bimekizumab in Patients With Moderate to Severe Plaque Psoriasis: Results from BE READY, a 56-Week Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study With Randomized Withdrawal”. SKIN The Journal of Cutaneous Medicine 4, no. 6 (October 27, 2020): s83. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/1116.